MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 26.22
+0.34 (1.31%)
Oct 22, 2026, 5:35 PM CEST
MedinCell Market Cap
MedinCell has a market cap or net worth of €941.6 million as of October 22, 2026. It is the 9,683rd most valuable company in the world and the 140th biggest in France. Its market cap has decreased by 19.85% in one year.
Market Cap
941.60M
Enterprise Value
928.70M
Revenue
24.28M
Global Rank
Country Rank
#140 France
PE Ratio
n/a
ChartMarket Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 941.60M, an increase of 544.46%. That is a compound annual growth rate of 26.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 941.60M | 12.88% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 6.86B |
| Nanobiotix | 940.52M |
| Inventiva | 640.32M |
| DBV Technologies | 467.84M |
| Valneva SE | 450.41M |
| Genfit | 417.76M |
| Valerio Therapeutics Société anonyme | 203.03M |
| Transgene | 184.05M |